Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function

Daihiko Hakuno, Keiichi Fukuda

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)


Cardiac valves are recognized as avascular tissue as well as cartilage and eye. We recently identified chondromodulin-I as crucial anti-angiogenic factor for maintaining cardiac valvular function. chondromodulin-I was first detected at developmental stage E9.5 in outflow tract, valvular primordium, and left ventricle, but was restricted to cardiac valves from late embryogenesis to adult. In ApoE(-/-) mice and human valvular heart diseases such as atherosclerosis, rheumatic heart diseases, and infective endocarditis, vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP) expression and neovascularization were observed in the area of down-regulation of chondromodulin-I. Conditioned medium from cultured-valvular interstitial cells strongly inhibited tube formation and migration of endothelial cells, and these effects were partially blocked by chondromodulin-I siRNA in vitro. Gene targeting of chondromodulin-I caused VEGF expression, neovascularization, lipid deposition, and calcification in cardiac valves of aged mice. Echocardiography showed aortic valve thickening and turbulent flow suggesting early stage of aortic stenosis. These findings provide evidence that chondromodulin-I is a crucial factor for maintaining normal cardiac valvular function by preventing angiogenesis that may lead to valvular heart diseases.

Original languageEnglish
Pages (from-to)361-372
Number of pages12
JournalClinical calcium
Issue number3
Publication statusPublished - 2007 Mar

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function'. Together they form a unique fingerprint.

Cite this